Intracranial Haemorrhage
Critical Alerts
- Time-critical diagnosis: CT head without contrast immediately
- Blood pressure management is crucial: Aggressive lowering for ICH (target SBP <140)
- Reverse anticoagulation urgently: Every minute counts for hematoma expansion
- SAH may have negative CT: LP required if high suspicion and CT normal
- Herniation signs require immediate action: Osmotherapy and neurosurgery
- Airway protection: GCS ≤8 requires intubation
Key Diagnostics
| Test | Finding | Significance |
|---|---|---|
| CT Head Non-Contrast | Hyperdense lesion | Gold standard initial imaging |
| CT Angiography | Spot sign, aneurysm, AVM | Identifies source, predicts expansion |
| LP (if CT-negative SAH suspected) | Xanthochromia, elevated RBCs | Diagnoses SAH |
| Coagulation studies | PT/INR elevated | Guides reversal therapy |
| Platelet count | Thrombocytopenia | May need transfusion |
Emergency Treatments
| Condition | Treatment | Details |
|---|---|---|
| BP control (ICH) | Nicardipine or Labetalol | Target SBP <140 mmHg |
| Warfarin reversal | 4-factor PCC + Vitamin K | 25-50 units/kg + 10mg IV |
| DOAC reversal | Idarucizumab (dabigatran) or Andexanet/PCC | Per protocol |
| Elevated ICP | Mannitol or Hypertonic saline | 1g/kg or 23.4% 30mL |
| Seizure prophylaxis | Levetiracetam | 20mg/kg IV (controversial) |
Overview
Intracranial haemorrhage (ICH) refers to bleeding within the cranial vault, including the brain parenchyma, subarachnoid space, subdural space, or epidural space. It is a medical emergency with high mortality and morbidity requiring rapid diagnosis, blood pressure control, reversal of anticoagulation, and neurosurgical evaluation.
Classification
By Location:
| Type | Location | Common Causes |
|---|---|---|
| Intracerebral (ICH) | Within brain parenchyma | Hypertension, CAA, AVM |
| Subarachnoid (SAH) | Subarachnoid space | Aneurysm rupture, trauma |
| Subdural (SDH) | Between dura and arachnoid | Trauma, bridging vein tear |
| Epidural (EDH) | Between dura and skull | Trauma, middle meningeal artery |
| Intraventricular (IVH) | Within ventricles | Extension from ICH, SAH |
Intracerebral Hemorrhage by Location:
| Location | % of ICH | Etiology |
|---|---|---|
| Basal ganglia/Thalamus | 50% | Hypertension |
| Lobar | 35% | CAA, tumor, AVM |
| Cerebellum | 10% | Hypertension |
| Brainstem | 5% | Hypertension (high mortality) |
Epidemiology
- ICH incidence: 10-30 per 100,000/year
- SAH incidence: 6-9 per 100,000/year
- ICH mortality: 30-50% at 30 days
- SAH mortality: 25-50% overall
- Age: Increases with age; median age 65-70 for ICH
- Anticoagulation-related: 12-20% of all ICH (increasing)
Etiology
Intracerebral Hemorrhage:
| Cause | Risk Factors |
|---|---|
| Hypertension (60-70%) | Uncontrolled HTN, noncompliance |
| Cerebral amyloid angiopathy (10-30%) | Age >5, recurrent lobar |
| Anticoagulation | Warfarin, DOACs, heparin |
| Vascular malformations | AVM, cavernoma, aneurysm |
| Hemorrhagic transformation of ischemic stroke | Post-tPA, large infarct |
| Tumor-related | Primary or metastatic |
| Cocaine/Amphetamines | Drug-induced HTN |
| Coagulopathy | DIC, liver failure, thrombocytopenia |
Subarachnoid Hemorrhage:
| Cause | Frequency |
|---|---|
| Aneurysm rupture | 85% |
| Trauma | Variable |
| Perimesencephalic (benign) | 10% |
| AVM/DAVF | 5% |
| Other (coagulopathy, vasculitis, drugs) | <5% |
Intracerebral Hemorrhage Progression
- Initial hemorrhage: Vessel rupture (arteriole in HTN, small vessels in CAA)
- Hematoma formation: Blood accumulates in parenchyma
- Hematoma expansion: Occurs in 30-40% within first hours (poor prognosis)
- Mass effect: Compression of adjacent tissue, midline shift
- Cerebral edema: Perihematomal edema develops over days
- Secondary injury: Inflammation, blood breakdown products, ischemia
Factors Promoting Hematoma Expansion
- Elevated blood pressure
- Anticoagulation
- Coagulopathy
- "Spot sign" on CTA (active extravasation)
- Early presentation (<3 hours)
Subarachnoid Hemorrhage Pathophysiology
- Aneurysm rupture: Sudden high-pressure bleeding into subarachnoid space
- Acute effects: Increased ICP, decreased CBF, loss of consciousness
- Early brain injury: Global ischemia, cortical spreading depression
- Rebleeding risk: Highest in first 24 hours (4% on day 1)
- Vasospasm: Days 3-14 (peaks day 7-10); major cause of delayed morbidity
- Hydrocephalus: Acute or chronic; blood blocks CSF absorption
Herniation Syndromes
| Type | Pathology | Signs |
|---|---|---|
| Uncal | Temporal lobe through tentorium | Ipsilateral dilated pupil, contralateral hemiparesis |
| Central | Downward bilateral displacement | Bilateral pupil dilation, posturing |
| Subfalcine | Under falx cerebri | Contralateral leg weakness |
| Tonsillar | Through foramen magnum | Respiratory arrest |
Intracerebral Hemorrhage
Symptoms:
Symptoms by Location:
| Location | Presentation |
|---|---|
| Basal ganglia | Contralateral hemiparesis, hemisensory loss |
| Thalamus | Hemisensory loss, small reactive pupils, downgaze palsy |
| Lobar | Focal signs depend on lobe; seizures more common |
| Cerebellum | Ataxia, vertigo, nausea, headache, cranial nerve palsies |
| Pontine | Coma, quadriplegia, pinpoint pupils, high mortality |
Subarachnoid Hemorrhage
Classic Presentation:
"Warning Leak" (Sentinel Headache):
Physical Examination
General:
Neurological:
| Finding | Significance |
|---|---|
| Pupil asymmetry | Herniation (CN III compression) |
| Hemiparesis | Contralateral lesion |
| Gaze deviation | Toward lesion (hemispheric); away from lesion (brainstem) |
| Meningismus | SAH |
| Papilledema | Elevated ICP (takes hours to develop) |
| Subhyaloid hemorrhage | SAH (Terson syndrome) |
Immediate Life Threats
| Finding | Concern | Action |
|---|---|---|
| Unilateral dilated pupil | Uncal herniation | Osmotherapy, hyperventilation, emergent surgery |
| GCS ≤8 | Unable to protect airway | Intubate |
| Cushing's triad | Elevated ICP | Osmotherapy, neurosurgery |
| Rapidly declining GCS | Hematoma expansion or herniation | Repeat CT, emergent intervention |
| Seizure | Ongoing neuronal injury | Benzodiazepines, antiepileptic loading |
| Anticoagulated + ICH | Ongoing bleeding | Immediate reversal |
Poor Prognostic Indicators (ICH)
- Large hematoma volume (>30 mL supratentorial, >15 mL infratentorial)
- Intraventricular extension
- Low GCS at presentation
- Age >80
- Anticoagulation
- Infratentorial location
- Spot sign on CTA (ongoing bleeding)
Other Causes of Sudden Severe Headache
| Diagnosis | Features | Evaluation |
|---|---|---|
| Ischemic stroke | Focal deficit without headache typically | CT, MRI |
| Migraine | Prior history, aura, photophobia | Clinical |
| Cervical artery dissection | Neck pain, Horner's, focal signs | CTA neck |
| Meningitis | Fever, meningismus, photophobia | LP |
| Reversible cerebral vasoconstriction syndrome | Recurrent thunderclap headaches | CTA/MRA |
| Pituitary apoplexy | Visual loss, ophthalmoplegia | MRI pituitary |
| Hypertensive encephalopathy | Severely elevated BP, no focal signs | PRES on MRI |
Imaging
CT Head Non-Contrast (First-Line):
- Immediately abnormal for acute hemorrhage
- Identifies location, volume, mass effect, hydrocephalus
- Sensitivity for SAH: 95-100% in first 6 hours; decreases with time
CT Angiography (CTA):
| Indication | Purpose |
|---|---|
| SAH | Identify aneurysm |
| ICH (non-hypertensive location) | Look for underlying lesion |
| "Spot sign" assessment | Predicts hematoma expansion |
| Young patient with lobar ICH | AVM, cavernoma, aneurysm |
MRI:
- Better for underlying lesions, cavernomas
- Gradient echo/SWI for microbleeds (CAA)
- Not emergent for diagnosis of acute hemorrhage
Lumbar Puncture (SAH):
- Indicated if CT negative but high clinical suspicion for SAH
- Wait 6-12 hours after symptom onset for xanthochromia to develop
- Findings: Elevated RBCs (non-clearing), xanthochromia (yellow supernatant)
Cerebral Angiography (DSA):
- Gold standard for aneurysm characterization
- May be needed if CTA inconclusive
- Performed by neurosurgery/neurointerventional
Laboratory Studies
| Test | Purpose |
|---|---|
| CBC | Platelet count, anemia |
| PT/INR, aPTT | Anticoagulation status |
| Fibrinogen | DIC, liver disease |
| BMP | Baseline renal function |
| Type and screen | Prepare for surgery/transfusion |
| Glucose | Hypoglycemia as cause of symptoms |
| Drug screen | Cocaine, amphetamines |
ICH Volume Estimation (ABC/2 Method)
Volume (mL) = (A × B × C) / 2
- A = largest diameter in cm
- B = perpendicular to A on same slice
- C = number of slices with hemorrhage × slice thickness
Principles of Management
- Airway protection: Intubate if GCS ≤8
- Blood pressure control: Reduce hematoma expansion
- Reverse anticoagulation: Urgently
- Prevent secondary injury: Glucose control, temperature, prevent seizures
- Manage elevated ICP: Osmotherapy, surgery if indicated
- Neurosurgery consultation: Early and always
Blood Pressure Management
Intracerebral Hemorrhage (AHA/ASA Guidelines):
| Presenting SBP | Target | Rationale |
|---|---|---|
| 150-220 mmHg | <140 mmHg | Safe; may reduce hematoma expansion |
| >20 mmHg | Aggressive reduction | Consider continuous infusion |
Agents:
| Agent | Dose | Notes |
|---|---|---|
| Nicardipine | 5-15 mg/hr IV | Titratable; first-line |
| Labetalol | 10-20 mg IV q10-20min | Max 300 mg |
| Clevidipine | 1-2 mg/hr IV | Titratable |
| Hydralazine | 10-20 mg IV | Less preferred (unpredictable) |
Subarachnoid Hemorrhage:
- More permissive BP until aneurysm secured
- Avoid hypotension (reduces perfusion)
- Target SBP <160-180 mmHg typically
Anticoagulation Reversal
Warfarin:
| Agent | Dose | Notes |
|---|---|---|
| 4-factor PCC (Kcentra) | 25-50 units/kg | Rapid reversal; INR-based dosing |
| Vitamin K | 10 mg IV | Takes hours to work; give concurrently |
| FFP | 10-15 mL/kg | If PCC unavailable; slower |
DOACs:
| Drug | Reversal Agent |
|---|---|
| Dabigatran | Idarucizumab 5g IV |
| Factor Xa inhibitors (rivaroxaban, apixaban, edoxaban) | Andexanet alfa or 4-factor PCC 50 units/kg |
Heparin: Protamine (1 mg per 100 units heparin)
Platelet Dysfunction/Thrombocytopenia:
- Platelet transfusion if count <100,000 and surgery planned
- DDAVP 0.3 mcg/kg for uremic platelet dysfunction
- Controversial for aspirin reversal (no proven benefit)
ICP Management
Tier 1:
- Head of bed 30°, head midline
- Analgesia and sedation
- Avoid hyperthermia, hypoxia, hypotension
Tier 2 - Osmotherapy:
| Agent | Dose | Notes |
|---|---|---|
| Mannitol | 1-1.5 g/kg IV | Osmolal gap <20; avoid if hypotensive |
| Hypertonic saline (23.4%) | 30 mL IV | Via central line preferred |
| Hypertonic saline (3%) | 250-500 mL | Can repeat |
Tier 3:
- Hyperventilation (temporary, PaCO2 30-35)
- Barbiturate coma
- Decompressive surgery
Seizure Management
Prophylaxis (Controversial in ICH):
- AHA guidelines: May consider for lobar ICH (higher seizure risk)
- Not routinely recommended for deep ICH without seizures
- Levetiracetam 20 mg/kg IV if used
Treatment of Active Seizures:
- Benzodiazepines → Levetiracetam or phenytoin loading
Surgical Management
Intracerebral Hemorrhage Indications:
| Indication | Consideration |
|---|---|
| Cerebellar hemorrhage > cm | Emergent surgery |
| Cerebellar with brainstem compression | Emergent surgery |
| Lobar clot >0 mL, <1 cm from surface | Consider evacuation |
| Deteriorating from mass effect | Consider surgery |
Subarachnoid Hemorrhage:
- Aneurysm securing: Surgical clipping or endovascular coiling
- Timing: Within 24-72 hours preferred
- EVD placement for hydrocephalus
Subdural Hematoma:
- Surgical evacuation for: Thickness >10mm, midline shift >5mm, GCS drop ≥2
Epidural Hematoma:
- Emergent craniotomy for symptomatic EDH or volume >30 mL
SAH-Specific Management
Nimodipine: 60 mg PO q4h × 21 days (reduces vasospasm-related poor outcome)
Vasospasm Monitoring: Transcranial Doppler, clinical exam
Triple-H Therapy (if vasospasm): Hypertension, hypervolemia, hemodilution (after aneurysm secured)
ICU Admission
- All ICH patients require ICU admission
- Dedicated Neurological ICU if available
- Frequent neurological checks (q1h)
- Continuous blood pressure monitoring
Neurosurgery Consultation
- Immediate for all intracranial hemorrhage
- Surgical decision-making
- ICP monitoring placement if indicated
- EVD for hydrocephalus
Transfer Considerations
- Transfer to comprehensive stroke center if surgery/intervention needed
- Time-critical; do not delay
- Stabilize before transfer (intubation, BP control, reversal started)
Goals of Care
- Early goals of care discussion
- Avoid early withdrawal of care (prognostication unreliable in first 24-48h)
For Families
- "Your loved one has bleeding in the brain, which is very serious."
- "We are working to stop the bleeding from getting bigger and to protect the brain."
- "They will need intensive care and possibly surgery."
- "The next few days are critical for understanding how they will recover."
Long-Term (Survivors)
- Blood pressure control is critical for prevention
- Medication compliance
- Follow-up imaging
- Rehabilitation services
- Driving restrictions
Prevention for At-Risk Patients
- Blood pressure control (most important)
- Avoid excessive anticoagulation
- Avoid cocaine and amphetamines
- Recognize warning signs
Anticoagulated Patients
- Highest priority: STOP and REVERSE anticoagulation immediately
- Higher mortality without reversal
- Do not wait for repeat imaging to start reversal
Elderly
- Higher prevalence of CAA
- More likely to be on anticoagulation
- Higher mortality
- Frailty impacts prognosis and surgical candidacy
Young Patients with ICH
- More likely to have underlying vascular lesion (AVM, aneurysm)
- More aggressive imaging workup
- Better recovery potential
Pregnancy
- Eclampsia as cause of ICH
- SAH risk increases in pregnancy
- Multidisciplinary management
- Consider delivery for term or near-term
Warfarin Users
- 7× increased risk of ICH
- Rapid reversal essential
- PCC preferred over FFP
Performance Indicators
| Metric | Target | Rationale |
|---|---|---|
| CT head within 25 minutes | 100% | Rapid diagnosis |
| BP <140 mmHg within 1 hour | >0% | Reduce expansion |
| Anticoagulation reversal initiated within 30 min | 100% | Stop bleeding |
| Neurosurgery consultation within 60 min | 100% | Surgical planning |
| DVT prophylaxis initiated (after 24-48h) | 100% | Prevent VTE |
| Goals of care documented | 100% | Appropriate care |
Documentation Requirements
- Time of symptom onset
- Initial and serial GCS
- Blood pressure and management
- Anticoagulation status and reversal
- CT findings including volume
- Neurosurgery consultation
- Goals of care discussion
Diagnostic Pearls
- Thunderclap headache = SAH until proven otherwise: LP if CT negative
- CT negative doesn't rule out SAH >6 hours: Need LP
- Spot sign on CTA: Active bleeding; predicts expansion
- Lobar hemorrhage in elderly: Think CAA
- Young patient + lobar ICH: Always look for underlying lesion
- Sentinel headache: May precede major SAH by days to weeks
Treatment Pearls
- Aggressive BP control for ICH: SBP <140 is safe
- Reverse anticoagulation immediately: PCC not FFP
- Careful with fluids: Avoid overload
- Mannitol needs good perfusion: Avoid if hypotensive
- Nimodipine for SAH: Oral, not IV (causes hypotension)
- Don't withdraw care early: Wait 48 hours minimum for prognosis
Disposition Pearls
- All ICH to ICU: No exceptions
- Cerebellar hemorrhage: Low threshold for surgery (can herniate rapidly)
- Goals of care early but not too early: Initial 24-48h prognosis unreliable
- Rehabilitation planning: Start early for survivors
- Hemphill JC, et al. Guidelines for the Management of Spontaneous Intracerebral Hemorrhage. Stroke. 2015;46(7):2032-2060.
- Connolly ES, et al. Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage. Stroke. 2012;43(6):1711-1737.
- Anderson CS, et al. Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage. N Engl J Med. 2013;368(25):2355-2365.
- Frontera JA, et al. Guidelines for reversal of antithrombotics in intracranial hemorrhage. Neurocrit Care. 2016;24(1):6-46.
- Qureshi AI, et al. Intracerebral haemorrhage. Lancet. 2009;373(9675):1632-1644.
- Diringer MN, et al. Critical care management of patients following aneurysmal subarachnoid hemorrhage. Neurocrit Care. 2011;15(2):211-240.
- Steiner T, et al. European Stroke Organisation (ESO) guidelines for the management of spontaneous intracerebral hemorrhage. Int J Stroke. 2014;9(7):840-855.
- UpToDate. Spontaneous intracerebral hemorrhage: Acute treatment and prognosis. 2024.